ascendis transcon
「ascendis transcon」熱門搜尋資訊
「ascendis transcon」文章包含有：「AscendisPharmaOpensCompassionateUseProgramfor...」、「AscendisPharmaPresentsTransCon™PTH...」、「AscendisPharmaProvidesUpdateonRegulatoryReviews...」、「AscendisPharmaReceivesPositiveCHMPOpinionfor...」、「AscendisPresentsTransCon™PTHDataattheAmerican...」、「Oncology」、「One」、「Technology」、「TransConCNP」、「TransConPTH」
查看更多
Ascendis Pharma Opens Compassionate Use Program for ...
https://investors.ascendisphar
Ascendis Pharma is applying its innovative TransCon technology platform to build a leading, fully integrated, global biopharma company focused ...
Ascendis Pharma Presents TransCon™ PTH ...
https://investors.ascendisphar
TransCon PTH (palopegteriparatide) is an investigational prodrug with sustained release of active parathyroid hormone (PTH [1-34]) administered ...
Ascendis Pharma Provides Update on Regulatory Reviews ...
https://investors.ascendisphar
Ascendis Pharma Provides Update on Regulatory Reviews of TransCon PTH™ in Hypoparathyroidism · U.S. EAP, which remains open for enrollment for ...
Ascendis Pharma Receives Positive CHMP Opinion for ...
https://investors.ascendisphar
TransCon PTH is a prodrug of parathyroid hormone (PTH [1-34]) administered once daily. “We are pleased to have received this positive CHMP ...
Ascendis Presents TransCon™ PTH Data at the American ...
https://investors.ascendisphar
TransCon PTH is an investigational prodrug with sustained release of active parathyroid hormone (PTH [1-34]) administered once daily. TransCon ...
Oncology
https://ascendispharma.com
Our TransCon technologies -- sustained systemic release and localized (intratumoral) release – can be applied to clinically validated targets and pathways from ...
One
https://investors.ascendisphar
COPENHAGEN, Denmark , June 17, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today reported one-year (Week 52) data from its ...
Technology
https://ascendispharma.com
TransCon is an innovative technology platform for drug development. It combines known biology with the benefits of prodrug and sustained-release technologies to ...
TransCon CNP
https://ascendispharma.com
TransCon CNP is an investigational prodrug of CNP in development for the treatment of ACH in children. Designed to provide continuous CNP exposure, the goal of ...
TransCon PTH
https://ascendispharma.com
TransCon PTH, an investigational long-acting prodrug of parathyroid hormone (PTH) designed to restore physiologic levels of PTH 24 hours a day.